e-Therapeutics PLC (LON:ETX) said it has successfully concluded its search for a new chief executive.
He is Dr Raymond Barlow, currently executive director of corporate development at Amgen, based in Switzerland.
The 48-year-old will join the AIM-listed drug discovery group on or before May 1.
He will take over day to day running of the company from Iain Ross, who is currently executive chairman of e-Therapeutics and fills the role vacated by Professor Malcolm Young, who stepped down last summer.
Barlow brings with him a “broad experience of drug discovery, development and commercialisation, acquired through regional and global roles in the biotech and pharmaceutical sector”, ETX said.
Chairman Ross said of the new chief executive: “He joins the company at an exciting time and is a consummate business professional who brings a wealth of relevant experience from the international pharmaceutical and biotech sector.
“I am confident that, as CEO, he will lead us through the next stage of the company's development and achieve both our short and long term goals.”